Epibiotech Co., Ltd. (XKON:446440)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,000
-500 (-4.35%)
At close: Jul 31, 2025

Epibiotech Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2022FY 2021
Period Ending
Jul '25 Dec '22 Dec '21
Debt / Equity Ratio
0.420.420.28
Asset Turnover
0.040.04-
Inventory Turnover
14.2114.21-
Quick Ratio
1.291.293.37
Current Ratio
1.371.373.80
Return on Equity (ROE)
-62.73%-62.73%-
Return on Assets (ROA)
-28.39%-28.39%-
Return on Capital (ROIC)
-29.34%-29.34%-
Buyback Yield / Dilution
--0.60%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.